DIVISLAB
Divislab
Live Price
₹7,417.50
+169.00+2.33%
Conviction Scorecard
AI Momentum
50%Technical Rating
71%Analyst Sentiment
85%Market News & Buzz
📰
Recent news and updates for DIVISLAB will appear here soon.
Stockmo Analyst Rationale
AI Generated Insight
"Balanced market signals for DIVISLAB. The stock is currently consolidating with neutral technical indicators and fundamental alignment between current healthcare growth rates and prevailing valuation metrics."
Verified by Stockmo Intelligence Grid
Supporting Evidence
Citing cross-referenced internal documents and market technicals
About Divislab
Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as astaxanthin, beta-carotene, lycopene, canthaxanthin, apocarotenal, and vitamins used in the food, beverage, dietary supplement, pet food, and feed industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.
Frequently asked questions
As of the latest market session, Divislab (DIVISLAB) is trading at ₹7,417.5, representing a move of 2.33% from the previous close.
Divislab is listed and traded under the ticker symbol DIVISLAB on the National Stock Exchange of India (NSE) and Bombay Stock Exchange (BSE).
Today, Divislab's stock price moved by 2.33%. Long-term growth trends depend on company financials, technical moving averages, and sector momentum in the Healthcare industry.
Our proprietary AI Momentum engine calculates a 50% bullish probability for DIVISLAB stock over the next 3-5 days. View the live interactive chart on Stockmo to see dynamic technical forecasting.
Over the past 52 weeks, Divislab shares reached a high of ₹7,459 and hit a low of ₹5,636.5.
DIVISLAB exhibits standard volatility for a Healthcare stock, with an average daily trading volume of 4,48,777 shares. Detailed technical beta indicators are available on the Stockmo charting engine.
Divislab has a market capitalization of ₹196844.95 Cr, designating its size class inside the Healthcare sector.
Divislab has a current dividend yield of 41.00%. Companies may adjust payout ratios depending on quarterly earnings growth and reinvestment opportunities.
Divislab's trailing Price-to-Earnings (P/E) ratio is 76.91. This indicates how much investors are willing to pay for every rupee of the company's annual net earnings.
You can purchase Divislab (DIVISLAB) shares through any SEBI-registered stockbroker (such as Kite/Zerodha, Groww, or Angel One) by funding your trading account and executing a buy order on the NSE or BSE.
Divislab's financial health, solvency, growth, and quality metrics are tracked using our proprietary Multibagger V2 score. You can explore DIVISLAB's detailed 5-tier financial scorecard and compare it with market competitors on the Stockmo Multibagger Screener page.
Institutional order blocks and pristine support/resistance triggers for DIVISLAB are monitored in real-time. View live technical entry levels, stop loss bounds, and target prices on our interactive Supply & Demand Trading Engine or scan entire market segments using the Basket Scanner.
Divislab operates inside the Healthcare sector. You can analyze sector-wide trends, relative strengths, and locate top emerging leaders in this space using our Sector Analysis Hub.